1
|
Tepetam H, Karabulut Gul S, Alomari O, Caglayan M, Demircioglu O. Does shortening the duration of radiotherapy treatment in breast cancer increase the risk of radiation pneumonia: A retrospective study. Medicine (Baltimore) 2023; 102:e33303. [PMID: 36961146 PMCID: PMC10035996 DOI: 10.1097/md.0000000000033303] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/09/2023] [Accepted: 02/24/2023] [Indexed: 03/25/2023] Open
Abstract
Randomized studies evaluating hypofractionation and conventional fractionation radiotherapy treatments (RT) in patients with breast cancer have shown that hypofractionation achieves similar results to conventional fractionation in terms of survival and local control rates. It has also been shown that their long-term toxicities are similar. This study aimed to evaluate the effects of hypofractionated radiotherapy (H-RT) and conventional radiotherapy (C-RT) on lung toxicity and identify factors affecting this toxicity in patients with breast cancer. The study included 118 patients who underwent adjuvant RT following breast-conserving surgery (BCS). Out of these, 63 patients were assigned to receive C-RT, while the remaining 55 were assigned to receive H-RT. To clarify, we treated 63 patients with C-RT and 55 patients with H-RT. 60 patients were treated using 3-dimensional conformal radiotherapy (3DCRT) and 58 patients were treated using intensity modulated radiotherapy (IMRT). The patients were evaluated weekly for toxicity during radiotherapy (RT) treatment and were called every 3 months for routine controls after the treatment. The first control was performed 1 month after the treatment. Statistical analysis was performed using the SPSS20 program, and a P value of <.005 was considered statistically significant. The study found that the median age of the participants was 54.9 years and tomographic findings were observed in 70 patients. Radiological findings were detected at a median of 5 months after RT. The mean lung dose (MLD) on the treated breast side (referred to as ipsilateral lung or OAR) was 10.4 Gy for the entire group. Among patients who received 18 MV energy in RT, those with an area volume (V20) of the lung on the treated breast side >18.5%, those with a mean dose of the treated breast side lung (ipsilateral lung) >10.5 Gy, and those who received concurrent hormone therapy had significantly more tomographic findings. However, patients treated with YART had fewer tomographic findings. No symptomatic patients were observed during the follow-up period. Our findings show that the risk of lung toxicity is similar with H-RT and C-RT, and H-RT can be considered an effective and safe treatment option for breast cancer. The key factors affecting the development of lung toxicity were found to be the type of RT energy used, RT to the side breast, volume receiving 20 Gy in the side lung, side lung mean dose, and simultaneous hormonal therapy.
Collapse
Affiliation(s)
- Huseyin Tepetam
- Department of Radiation Oncology, Dr. Lutfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey
| | - Sule Karabulut Gul
- Department of Radiation Oncology, Dr. Lutfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey
| | - Omar Alomari
- Hamidiye International School of Medicine, University of Health Sciences, Istanbul, Turkey
| | - Merve Caglayan
- Department of Radiation Oncology, Dr. Lutfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey
| | - Ozlem Demircioglu
- Marmara University Research and Education Hospital, Department of Radiology, Istanbul, Turkey
| |
Collapse
|
2
|
Apaza Blanco OA, Almada MJ, Garcia Andino AA, Zunino S, Venencia D. Knowledge-Based Volumetric Modulated Arc Therapy Treatment Planning for Breast Cancer. J Med Phys 2021; 46:334-340. [PMID: 35261504 PMCID: PMC8853452 DOI: 10.4103/jmp.jmp_51_21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2021] [Revised: 07/19/2021] [Accepted: 07/21/2021] [Indexed: 11/24/2022] Open
Abstract
Purpose: To create and to validate knowledge-based volumetric modulated arc therapy (VMAT) models for breast cancer treatments without lymph node irradiation. Materials and Methods: One hundred VMAT-based breast plans (manual plans [MP]) were selected to create two knowledge-based VMAT models (breast left and breast right) using RapidPlan™. The plans were generated on Eclipse v15.5 (Varian Medical Systems, Palo Alto, CA) with 6 MV of a Novalis Tx equipped with a high-resolution multileaf collimator. The models were verified based on goodness-of-fit statistics using the coefficients of determination (R2) and Chi-square (χ2), and the goodness-of-estimation statistics through the mean square error (MSE). Geometrical and dosimetrical constraints were identified and removed from the RP models using statistical evaluation metrics and plots. For validation, 20 plans that integrate the models and 20 plans that do not were reoptimized with RP (closed and opened validation). Dosimetrical parameters of interest were used to compare MP versus RP plans for the Heart, Homolateral_Lung, Contralateral_Lung, and Contralateral_Breast. Optimization planning time and user independency were also analyzed. Results: The most unfavorable results of R2 in both models for the organs at risk were as follows: for Contralateral_Lung 0.51 in RP right breast (RP_RB) and for Heart 0.60 in RP left breast (RP_LB). The most unfavorable results of χ2 test were: for Contralateral_Breast 1.02 in RP_RB and for Heart 1.03 in RP_LB. These goodness-of-fit results show that no overfitting occurred in either of the models. There were no unfavorable results of mean square error (MSE, all < 0.05) in any of the two models. These goodness-of-estimation results show that the models have good estimation power. For closed validation, significant differences were found in RP_RB for Homolateral_Lung (all P ≤ 0.001), and in the RP_LB differences were found for the heart (all P ≤ 0.04) and for Homolateral_Lung (all P ≤ 0.022). For open validation, no statistically significant differences were obtained in either of the models. RP models had little impact on reducing optimization planning times for expert planners; nevertheless, the result showed a 30% reduction time for beginner planners. The use of RP models generates high-quality plans, without differences from the planner experience. Conclusion: Two RP models for breast cancer treatment using VMAT were successfully implemented. The use of RP models for breast cancer reduces the optimization planning time and improves the efficiency of the treatment planning process while ensuring high-quality plans.
Collapse
Affiliation(s)
- Oscar Abel Apaza Blanco
- Department of Medical Physics, Instituto Zunino - Fundación Marie Curie, Obispo Oro 423, X5000 BFI, Córdoba, Argentina
| | - María José Almada
- Department of Medical Physics, Instituto Zunino - Fundación Marie Curie, Obispo Oro 423, X5000 BFI, Córdoba, Argentina
| | - Albin Ariel Garcia Andino
- Department of Medical Physics, Instituto Zunino - Fundación Marie Curie, Obispo Oro 423, X5000 BFI, Córdoba, Argentina
| | - Silvia Zunino
- Department of Medical Physics, Instituto Zunino - Fundación Marie Curie, Obispo Oro 423, X5000 BFI, Córdoba, Argentina
| | - Daniel Venencia
- Department of Medical Physics, Instituto Zunino - Fundación Marie Curie, Obispo Oro 423, X5000 BFI, Córdoba, Argentina
| |
Collapse
|
3
|
Jin X, Lin B, Chen D, Li L, Han C, Zhou Y, Zheng X, Gong C, Chen M, Xie C. Safety and outcomes of volumetric modulated arc therapy in the treatment of patients with inoperable lung cancer. J Cancer 2019; 10:2868-2873. [PMID: 31281463 PMCID: PMC6590029 DOI: 10.7150/jca.31260] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2018] [Accepted: 04/14/2019] [Indexed: 12/19/2022] Open
Abstract
Background: Published data on the effects and toxicities of volumetric modulated arc therapy (VMAT) in the management of inoperable lung cancer are scarce. Materials and methods: The clinical outcomes and pulmonary toxicities of 134 patients with consecutive inoperable lung cancer who underwent VMAT from March 2011 to September 2016 were retrospectively reviewed. The dosimetric and characteristic factors associated with acute radiation pneumonitis (RP) and pulmonary fibrosis were evaluated with univariate and multivariate analysis. Results: The average prescription doses to these 134 patients were 57.07±6.27 Gy (range 52-64 Gy). The overall median follow-up time was 18.6 months (range, 2-45 mo), with a median follow-up time for the surviving patients of 20 months (range, 7-45 mo). The 2-year progression-free survival (PFS) and overall survival (OS) for all patients were 18.2% and 38.4%, with a median PFS and OS of 7.6 months and 18.6 months, respectively. The percent of patients with grade III/higher RP and pulmonary fibrosis were 10.5% and 9.0%, respectively. V13 (p=0.02) and age (p=0.02) were independently associated with acute RP according to multivariate analysis. The constraints for lung dosimetric metrics V10,V13,V20 and V30 were approximately 49%,41%,26% and 17% in VMAT treatment of lung cancer to limit the RP rate < 10%. Conclusion: VMAT can be delivered safely with acceptable acute and late toxicities for lung cancer patients. Lung dosimetric metrics were valuable in predicting acute RP. A lung V13 constraint of 40% was helpful to limit the RP rate < 10% in VMAT treatment of lung cancer patients.
Collapse
Affiliation(s)
- Xiance Jin
- Radiation and Medical Oncology, the first Affiliated Hospital of Wenzhou Medical University, Wenzhou, China,325000
| | - Baochai Lin
- Radiation and Medical Oncology, the first Affiliated Hospital of Wenzhou Medical University, Wenzhou, China,325000
| | - Didi Chen
- Radiation and Medical Oncology, the first Affiliated Hospital of Wenzhou Medical University, Wenzhou, China,325000
| | - Lili Li
- Radiation and Medical Oncology, the first Affiliated Hospital of Wenzhou Medical University, Wenzhou, China,325000
| | - Ce Han
- Radiation and Medical Oncology, the first Affiliated Hospital of Wenzhou Medical University, Wenzhou, China,325000
| | - Yongqiang Zhou
- Radiation and Medical Oncology, the first Affiliated Hospital of Wenzhou Medical University, Wenzhou, China,325000
| | - Xiaomin Zheng
- Radiation and Medical Oncology, the first Affiliated Hospital of Wenzhou Medical University, Wenzhou, China,325000
| | - Changfei Gong
- Radiation and Medical Oncology, the first Affiliated Hospital of Wenzhou Medical University, Wenzhou, China,325000
| | - Mengfeng Chen
- Respiratory Department, Third People's Hospital of Yueqing, Wenzhou, China, 325600
| | - Congying Xie
- Radiation and Medical Oncology, the first Affiliated Hospital of Wenzhou Medical University, Wenzhou, China,325000
| |
Collapse
|
4
|
Rehman JU, Zahra, Ahmad N, Khalid M, Noor ul Huda Khan Asghar H, Gilani ZA, Ullah I, Nasar G, Akhtar MM, Usmani MN. Intensity modulated radiation therapy: A review of current practice and future outlooks. JOURNAL OF RADIATION RESEARCH AND APPLIED SCIENCES 2019. [DOI: 10.1016/j.jrras.2018.07.006] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- Jalil ur Rehman
- Department of Physics, Baluchistan University of Information Technology, Engineering & Management Sciences, Quetta, 87300, Pakistan
| | - Zahra
- Department of Physics, Baluchistan University of Information Technology, Engineering & Management Sciences, Quetta, 87300, Pakistan
| | - Nisar Ahmad
- Department of Physics, Baluchistan University of Information Technology, Engineering & Management Sciences, Quetta, 87300, Pakistan
| | - Muhammad Khalid
- Department of Physics, Baluchistan University of Information Technology, Engineering & Management Sciences, Quetta, 87300, Pakistan
| | - H.M. Noor ul Huda Khan Asghar
- Department of Physics, Baluchistan University of Information Technology, Engineering & Management Sciences, Quetta, 87300, Pakistan
| | - Zaheer Abbas Gilani
- Department of Physics, Baluchistan University of Information Technology, Engineering & Management Sciences, Quetta, 87300, Pakistan
| | - Irfan Ullah
- Centre for Nuclear Medicine and Radiotherapy (CENAR), Quetta, Pakistan
| | - Gulfam Nasar
- Department of Chemistry, Baluchistan University of Information Technology, Engineering & Management Sciences, Quetta, Pakistan
| | - Malik Muhammad Akhtar
- Department of Environmental Science, Baluchistan University of Information Technology, Engineering & Management Sciences, Quetta, Pakistan
| | | |
Collapse
|
5
|
Rozanec N, Allibhai Z, Bhatti M, Chan E, McIntosh M, Moseley D, Taremi M, Abbas A. Palliation of Vertebral Metastases with Radiotherapy: Exploration of Volumetric-Modulated Arc Therapy From Development to Implementation in Routine Clinical Practice. J Med Imaging Radiat Sci 2018; 50:68-73. [PMID: 30777251 DOI: 10.1016/j.jmir.2018.09.001] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2018] [Revised: 08/20/2018] [Accepted: 09/06/2018] [Indexed: 12/25/2022]
Abstract
The development of volumetric-modulated arc therapy (VMAT) in radiation therapy has allowed for improved dose escalation and a decrease in radiation-induced toxicities for patients. This article will describe a single centre's experience in development and implementation of VMAT for palliation of vertebral metastases. A retrospective planning analysis of 10 cases identified that utilization of VMAT decreases overall planning time with a statistically significant improvement in target coverage when compared with the current conventional technique. PTV Dmax (P = .02), PTV V9519Gy (95%) (P = .01), dose conformation (P = 1.8e-004), and the homogeneity index (P = .019) were all superior for VMAT plans with an average PTV length of 22.46 cm. Another benefit of VMAT utilization is a significant decrease in treatment delivery time, which reduced treatment times from 9.95 minutes to 2.98 minutes. Immobilization was also carefully considered, and rotational errors were measured and fell within institutional tolerances when VMAT was delivered using simple immobilization devices. Clinical implementation of this technique, utilizing a highly conformal target volume to decrease radiation-induced toxicities and minimizing the length of time patients are required to maintain their treatment positions, aims to improve the palliative radiotherapy experience for patients with painful spinal metastases.
Collapse
Affiliation(s)
- Natalie Rozanec
- Southlake Regional Health Centre, Newmarket, Ontario, Canada; Sheffield Hallam University, Sheffield, United Kingdom.
| | - Zishan Allibhai
- Southlake Regional Health Centre, Newmarket, Ontario, Canada; The Princess Margaret Cancer Centre, Toronto, Ontario, Canada
| | - Michael Bhatti
- Southlake Regional Health Centre, Newmarket, Ontario, Canada
| | - Edwin Chan
- Southlake Regional Health Centre, Newmarket, Ontario, Canada
| | - Marlyn McIntosh
- Southlake Regional Health Centre, Newmarket, Ontario, Canada
| | - Douglas Moseley
- Southlake Regional Health Centre, Newmarket, Ontario, Canada; The Princess Margaret Cancer Centre, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada
| | - Mojgan Taremi
- Southlake Regional Health Centre, Newmarket, Ontario, Canada; The Princess Margaret Cancer Centre, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada
| | - Ahmar Abbas
- Southlake Regional Health Centre, Newmarket, Ontario, Canada
| |
Collapse
|
6
|
Modulated radiotherapy for head and neck carcinomas: an outcome study. JOURNAL OF RADIOTHERAPY IN PRACTICE 2018. [DOI: 10.1017/s1460396918000183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
AbstractBackgroundTo evaluate the survival outcomes and toxicities experienced by non-metastatic head and neck cancer (HNC) patients receiving modulated radiotherapy (RT).Materials and methodsA total of 608 HNC patients treated consecutively from March 2010 to December 2014 with common subsites (oral cavity, oropharynx, hypopharynx, larynx and nasopharynx) of HNCs formed the study group. Eligible patients included those treated with radical or postoperative RT between March 2010 and December 2014. More than 90% patients received modulated RT [intensity-modulated radiotherapy (IMRT) or volumetric-modulated arc therapy (VMAT)] with concurrent chemotherapy as per stage guidelines. Demographic parameters and disease-related factors were analysed. Disease-free survival (DFS) was calculated from end date of RT till last follow-up or last date of disease control. Overall survival (OS) was calculated from date of registration to last follow-up date if alive. The primary endpoint was survival. The statistical analyses were performed using SPSS version 20.0 and Kaplan–Meier method was used for calculation survival.ResultsAmong the evaluable patients, the median age was 60 years (range: 16–93) with male preponderance (male:female – 513:95). Majority were squamous cell carcinoma 93·4% (568/608). The subsites treated were oral cavity 36·8% (224). oropharynx 26·4% (161), larynx 19·7% (120), hypopharynx 10% (62) and nasopharynx 6·4% (41). RT intent was radical in 63·5% (386) and postoperative in 36·5% (222), with 59·5% (362) receiving concurrent chemotherapy. At last follow-up, 348 (57·2%) patients were alive, 169 (27·7%) patients had succumbed to disease and 120 (24·6%) patients had recurrent disease. Out of 120 recurrent cases loco-regional recurrence, nodal recurrence and distant metastases were seen in 62 (51·7%), 25 (20·8%), 33 (27·5%), respectively. In the entire study cohort at 2 year OS and DFS was 80 and 79% whereas 3 years OS and DFS was 70 and 75%, respectively.ConclusionsIn our study, 2 years and 3 years OS and DFS rates are found comparable to the international data with acceptable toxicity profile with the use of modulated RT. It seems to be possible because of stringent departmental protocols and good medical physics support. Our data re-validates need and benefit of advanced RT techniques like IG-IMRT and VMAT for both postoperative and radical HNC treatment at the cost of minimal long-term side effects. Future stringent follow-up and quality of life issues are being considered in a prospective manner.
Collapse
|
7
|
Thongsawad S, Khamfongkhruea C, Tannanonta C. Dosimetric Effect of Jaw Tracking in Volumetric-Modulated Arc Therapy. J Med Phys 2018; 43:52-57. [PMID: 29628634 PMCID: PMC5879824 DOI: 10.4103/jmp.jmp_75_17] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
The aim of this study was to investigate the potential of jaw tracking with the volumetric-modulated arc therapy (VMAT) to reduce the normal tissue dose. Plans of nasopharynx, lung, and prostate cancers (10 plans for each) were used to perform VMAT with and without jaw tracking. The dose reduction was evaluated in terms of organ doses and integral doses. Organ-dose reduction with jaw tracking was statistically significant in the volume receiving a dose of 5 Gy (V5) of bladder, rectum, and lung, the volume receiving a dose of 10 Gy (V10) of bladder, rectum, and lung, and the mean dose of lung (P < 0.05). Integral-dose reduction with jaw tracking was statistically significant in almost all the treatment plans (P < 0.05). For organ-dose reduction, jaw tracking in VMAT plan was effective in reducing V5 and V10. For integral-dose reduction, jaw tracking in VMAT plan is an efficient method for decreasing V5.
Collapse
|
8
|
Bostel T, Pfaffenberger A, Delorme S, Dreher C, Echner G, Haering P, Lang C, Splinter M, Laun F, Müller M, Jäkel O, Debus J, Huber PE, Sterzing F, Nicolay NH. Prospective feasibility analysis of a novel off-line approach for MR-guided radiotherapy. Strahlenther Onkol 2018; 194:425-434. [DOI: 10.1007/s00066-017-1258-y] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2017] [Accepted: 12/22/2017] [Indexed: 10/18/2022]
|
9
|
Wang SJ, Choi M, Fuller CD, Salter BJ, Fuss M. Intensity-Modulated Radiosurgery for Patients with Brain Metastases: A Mature Outcomes Analysis. Technol Cancer Res Treat 2016; 6:161-8. [PMID: 17535023 DOI: 10.1177/153303460700600302] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
The purpose of this study was to evaluate the outcomes of patients with brain metastases treated by tomotherapeutic Intensity-modulated Radiosurgery (IMRS). Using retrospective chart review, we analyzed the outcomes of 78 patients (age 33–83 years, median 57 years) who underwent 111 sessions of IMRS (1 to 7 sessions per patient, median 1) for brain metastases (1 to 4 targets per IMRS session, median 1) treated between 2000 and 2005 using a serial tomotherapeutic intensity-modulated radiotherapy treatment (IMRT) planning and delivery system (Peacock, Nomos Corp., Cranberry Township, PA). Treatment planning was performed using an inverse treatment planning optimization algorithm that was optimized for IMRS. A median prescription dose of 15 Gy in combination with WBI, and median 20 Gy for IMRS alone was delivered using 2–4 couch angles over 4–24 rotational arcs. Overall survival was calculated using Kaplan-Meier analysis. To determine the effects of prognostic variables on survival, univariate and multivariate analyses using proportional hazards were performed to assess the effects of age, tumor size, the combination with whole brain irradiation, presence of multiple brain metastases, and presence of extracranial disease. The median overall survival was 6.5 months (95% CI, 5.5–7.9). One- and two-year survival rates were 24% and 10%. In multivariate analyses, age greater than 60 years was the only statistically significant variable that affected survival (hazard rate 1.29, p=0.049). We conclude that tomotherapeutic IMRS is safe and effective to treat patients with brain metastases.
Collapse
Affiliation(s)
- Samuel J Wang
- Department of Radiation Medicine, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, MC L337, Portland, Oregon 97239, USA.
| | | | | | | | | |
Collapse
|
10
|
Wiesendanger-Wittmer EM, Sijtsema NM, Muijs CT, Beukema JC. Systematic review of the role of a belly board device in radiotherapy delivery in patients with pelvic malignancies. Radiother Oncol 2012; 102:325-34. [PMID: 22364650 DOI: 10.1016/j.radonc.2012.02.004] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2011] [Revised: 02/01/2012] [Accepted: 02/07/2012] [Indexed: 11/19/2022]
Abstract
PURPOSE This review analyses the literature concerning the influence of the patient position (supine, prone and prone on a belly board device (BB) on the irradiated small-bowel-volume (SB-V)) and the resulting morbidity of radiation therapy (RT) in pelvic malignancies. METHODS A literature search was performed in MEDLINE, web of science and Scopus. RESULTS Forty-six full papers were found, of which 33 met the eligibility criteria. Fifteen articles focussed on the irradiated SB-V using dose volume histograms (DVHs). Twenty-seven articles studied the patient setup in different patient positions. This review showed that a prone treatment position can result in a lower irradiated SB-V as compared to a supine position, but a more significant reduction of the SB-V can be reached by the additional use of a BB in prone position, for both 3D-CRT and IMRT treatment plans. This reduction of the irradiated SB-V might result in a reduced GI-morbidity. The patient position did not influence the required PTV margins for prostate and rectum. CONCLUSIONS The irradiated SB-V can be maximally reduced by the use of a prone treatment position combined with a BB for both 3D-CRT and IMRT, which might individually result in a reduction of GI-morbidity.
Collapse
|
11
|
Teoh M, Clark CH, Wood K, Whitaker S, Nisbet A. Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol 2011; 84:967-96. [PMID: 22011829 DOI: 10.1259/bjr/22373346] [Citation(s) in RCA: 421] [Impact Index Per Article: 32.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
Volumetric modulated arc therapy (VMAT) is a novel radiation technique, which can achieve highly conformal dose distributions with improved target volume coverage and sparing of normal tissues compared with conventional radiotherapy techniques. VMAT also has the potential to offer additional advantages, such as reduced treatment delivery time compared with conventional static field intensity modulated radiotherapy (IMRT). The clinical worldwide use of VMAT is increasing significantly. Currently the majority of published data on VMAT are limited to planning and feasibility studies, although there is emerging clinical outcome data in several tumour sites. This article aims to discuss the current use of VMAT techniques in practice and review the available data from planning and clinical outcome studies in various tumour sites including prostate, pelvis (lower gastrointestinal, gynaecological), head and neck, thoracic, central nervous system, breast and other tumour sites.
Collapse
Affiliation(s)
- M Teoh
- Department of Oncology, St Luke's Cancer Centre, Royal Surrey County Hospital, Guildford, Surrey, UK.
| | | | | | | | | |
Collapse
|
12
|
Abstract
Modern combination chemotherapy and radiotherapy regimens have a substantial negative impact on reproduction. Premature ovarian failure and other poor reproductive outcomes subsequent to cancer therapies are being recognized. Furthermore, beside malignancies, treatment of certain precancerous and benign conditions such as myelodysplasia, aplastic anemia, and systemic lupus erythematosus may necessitate administration of high-dose chemotherapeutics with and without stem cell transplantation. Therefore, preservation of gonadal function and fertility has become one of the major quality of life issues for cancer survivors at reproductive ages. In this review, premature ovarian failure and other adverse reproductive outcomes in female patients who receive chemotherapy and radiation will be discussed and the options to preserve their fertility will be delineated. After completion of the educational activity, the reader will be better able to distinguish the experimental approaches to minimizing gonadotoxic therapy, and use the most effective treatment options.
Collapse
|
13
|
Ahn YC. Introduction of intensity modulated radiation therapy. JOURNAL OF THE KOREAN MEDICAL ASSOCIATION 2011. [DOI: 10.5124/jkma.2011.54.11.1172] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Affiliation(s)
- Yong Chan Ahn
- Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| |
Collapse
|
14
|
Hu YC, Chang CH, Chen CH, Ger LP, Liu WS, Lin LC, Leung CM, Chang KC. Impact of intracranial extension on survival in stage IV nasopharyngeal carcinoma: identification of a subset of patients with better prognosis. Jpn J Clin Oncol 2010; 41:95-102. [PMID: 20852300 DOI: 10.1093/jjco/hyq171] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
OBJECTIVE T-stage is an imperfect prognostic indicator for patients with nasopharyngeal carcinoma. We evaluated the effect of extent of intracranial involvement on survival after conventional radiotherapy in patients with Stage T4 nasopharyngeal carcinoma. METHODS We conducted a retrospective analysis of the results of computed tomography, magnetic resonance imaging and treatment outcomes in 84 consecutive patients with Stage T4 nasopharyngeal carcinoma during the period September 1993 to December 2002 in Taiwan. The patients were subcategorized into those who had limited intracranial involvement (primary nasopharyngeal tumors with involvement of the unilateral cavernous sinus or the parasellar region only) or extensive involvement (extension of the tumors to the bilateral cavernous sinus or the parasellar region, into the orbit and the ethmoid sinus anteriorly, or to the prepontine region and the posterior cranial fossa). RESULTS Extensive intracranial involvement was found in 51.2% of the patients. Among these patients, the 5-year rate of overall survival after conventional radiotherapy was only 3.4%. In contrast, the 5-year survival among patients with limited intracranial involvement was 42.9%. This difference was significant (P < 0.001). In the multivariate analysis, extensive intracranial involvement, advanced age and a nodal status of N3 correlated with poor overall survival (all P < 0.05). CONCLUSIONS Among patients with T4 nasopharyngeal carcinoma, better treatment outcomes were associated with limited intracranial involvement. We conclude that a subdivision of Stage T4 nasopharyngeal carcinoma disease based on the extent of intracranial involvement would provide better prognostic information.
Collapse
Affiliation(s)
- Yu-Chang Hu
- Department of Radiation Oncology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
| | | | | | | | | | | | | | | |
Collapse
|
15
|
Oktay K, Oktem O. Fertility preservation medicine: a new field in the care of young cancer survivors. Pediatr Blood Cancer 2009; 53:267-73. [PMID: 19301406 DOI: 10.1002/pbc.22003] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
Treatment modalities for numerous oncological and non-oncological conditions result in gonadal insufficiency and infertility. Furthermore, pelvic-abdominal radiation may result in uterine damage resulting in poor reproductive outcomes such as preterm birth, low birth weight, and spontaneous abortion in adult survivors of childhood cancers. In response to the recognition of the impact of cancer treatments on fertility, several fertility preservation techniques have been developed. In prepubertal children, fertility preservation options are usually limited to ovarian cryopreservation because of sexual immaturity, but oocyte freezing can be performed in adolescent children. Two prospective randomized studies showed no benefit of gonadal suppression with GnRH analogs to preserve gonadal function and thus this treatment should not be recommended. For adult survivors of childhood cancer who experienced reproductive failure, third party reproduction techniques are highly successful.
Collapse
Affiliation(s)
- Kutluk Oktay
- Department of Obstetrics and Gynecology, New York Medical College, Valhalla, New York, USA.
| | | |
Collapse
|
16
|
Kun LE, Beltran C. Radiation therapy for children: evolving technologies in the era of ALARA. Pediatr Radiol 2009; 39 Suppl 1:S65-70. [PMID: 19083214 DOI: 10.1007/s00247-008-1098-0] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/26/2008] [Accepted: 11/28/2008] [Indexed: 10/21/2022]
Abstract
The evolution of ever more sophisticated oncologic imaging and technologies providing far more precise radiation therapy have combined to increase the utilization of sophisticated radiation therapy in childhood cancer. For a majority of children with common central nervous system, soft tissue, bone, and dysontogenic neoplasms, local irradiation is fundamental to successful multi-disciplinary management. Along with more precise target volume definition and radiation delivery, new technologies provide added certainty of patient positioning (electronic portal imaging, cone beam CT) and conformality of dose delivery (3-D conformal irradiation, intensity modulated radiation therapy, proton beam therapy). Each of the major areas of technology development are able to better confine the high-dose region to the intended target, but they are also associated with the potential for larger volumes of uninvolved tissues being exposed to low radiation doses. The latter issue plays a role in documented levels of secondary carcinogenesis, sometimes with greater anticipated incidence than that seen in conventional radiation therapy. Parameters related to carcinogenesis, such as dose-volume relationships and neutron contamination that accompanies high-energy photon irradiation and proton therapy, can be identified, sometimes modulated, and accepted as part of the clinical decision process in fine tuning radiation therapy in this more vulnerable age group.
Collapse
Affiliation(s)
- Larry E Kun
- Department of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
| | | |
Collapse
|
17
|
Oktem O, Oktay K. Preservation of menstrual function in adolescent and young females. Ann N Y Acad Sci 2008; 1135:237-43. [PMID: 18574230 DOI: 10.1196/annals.1429.033] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Every year thousands of young teenagers are afflicted with different types of cancer and receive gonadotoxic chemotherapy and radiotherapy regimens, causing depletion of germ cells in the gonads and premature gonadal failure. In this review, we discuss and outline the current strategies and the future directions of fertility preservation and ovarian cryopreservation and transplantation in adolescents and young females.
Collapse
Affiliation(s)
- Ozgur Oktem
- Department of Obstetrics and Gynecology, New York Medical College, Valhalla, New York, USA
| | | |
Collapse
|
18
|
Aristu JJ, Arbea L, Rodriguez J, Hernández-Lizoain JL, Sola JJ, Moreno M, Azcona JD, Díaz-González JA, García-Foncillas JM, Martínez-Monge R. Phase I-II trial of concurrent capecitabine and oxaliplatin with preoperative intensity-modulated radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2007; 71:748-55. [PMID: 18164861 DOI: 10.1016/j.ijrobp.2007.10.023] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2007] [Revised: 10/15/2007] [Accepted: 10/18/2007] [Indexed: 02/06/2023]
Abstract
PURPOSE To identify the maximal tolerated dose level of preoperative intensity-modulated radiotherapy combined with capecitabine and oxaliplatin and to evaluate the efficacy. PATIENTS AND METHODS Patients with rectal T3-T4 and/or N0-N+ rectal cancer received capecitabine 825 mg/m(2) twice daily Monday through Friday and oxaliplatin 60 mg/m(2) intravenously on Days 1, 8, and 15, concurrently with intensity-modulated radiotherapy. The radiation dose was increased in 5.0-Gy steps in cohorts of 3 patients starting from 37.5 Gy in 15 fractions (dose level [DL] 1). DL2 and DL3 were designed to reach 42.5 Gy in 17 fractions and 47.5 Gy in 19 fractions, respectively. RESULTS No dose-limiting toxicity was observed at DL1 or DL2. Of the 3 patients treated at DL3, 1 presented with Grade 3 diarrhea, which was considered a dose-limiting toxicity, and 3 additional patients were added. Of the 6 patients treated at DL3, no new dose-limiting toxicities were observed, and DL3 was identified as the recommended dose in this study. Eight additional patients were treated at 47.5 Gy. Grade 2 proctitis was the most frequent adverse event (40%); Grade 3 diarrhea occurred in 2 patients (10%). All patients underwent surgery, and 17 patients (85%) underwent R0 resection. Four patients (20%) presented with a histologic response of Grade 4, 11 (55%) with Grade 3+, 2 (15%) with Grade 3, and 2 patients (10%) with Grade 2. CONCLUSION The maximal tolerated dose in this study was 47.5 Gy. The high rates of pathologic response of Grade 3+ and 4 must be confirmed through the accrual of new patients in the Phase II study.
Collapse
Affiliation(s)
- José Javier Aristu
- Service of Radiation Oncology, Department of Oncology, Clínica Universitaria, University of Navarre, Pamplona, Spain.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Garsa AA, Andrade RS, Heron DE, Beriwal S, Kim H, Brandner E, Kuo G, Chen H, Gerszten K, Yue JN, Huq MS, Lee J, Lalonde R, Wu A. Four-dimensional computed tomography-based respiratory-gated whole-abdominal intensity-modulated radiation therapy for ovarian cancer: a feasibility study. Int J Gynecol Cancer 2007; 17:55-60. [PMID: 17291232 DOI: 10.1111/j.1525-1438.2006.00743.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
This study assesses the feasibility and implementation of respiratory-gated whole-abdominal intensity-modulated radiation therapy (RG-WAIMRT). Three patients were treated with RG-WAIMRT. The planning target volume (PTV1) included the entire peritoneal cavity and a pelvic boost field was created (PTV2). The dose prescribed was 30 Gy to PTV1 and 14.4 Gy to PTV2. For comparison, a conventional three-dimensional (3D) plan was generated for each patient. In the WAIMRT plan, an average of 90% of PTV1 received 30 Gy compared to 70% for the conventional 3D plan. The percent volume receiving 30 Gy (V30) for liver averaged 54% (WAIMRT) vs 43% (3D). The percent volume receiving 20 Gy (V20) for kidneys averaged 19% vs 0%, and the mean V20 for bone marrow was 74% vs 83%, respectively. Major acute toxicities were anemia (grade 2: 1/3), leukopenia (grade 3: 2/3 patients), and thrombocytopenia (grade 2: 1/3 patients, grade 3: 1/3 patients). One patient could not complete the whole-abdomen field after 19.5 Gy because of persistent nausea. No major subacute toxicity has been reported. WAIMRT demonstrated superior target coverage and reduced dose to bone marrow, with a slightly increased dose to liver and kidneys. WAIMRT is a novel and feasible technique for ovarian cancer treatment.
Collapse
Affiliation(s)
- A A Garsa
- University of Pittsburgh School of Medicine, Pittsburgh, PA 15232, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Newbold K, Partridge M, Cook G, Sohaib SA, Charles-Edwards E, Rhys-Evans P, Harrington K, Nutting C. Advanced imaging applied to radiotherapy planning in head and neck cancer: a clinical review. Br J Radiol 2006; 79:554-61. [PMID: 16823059 DOI: 10.1259/bjr/48822193] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
Head and neck squamous cell carcinoma represents an ideal model to investigate the application of recent advances in medical imaging to radiotherapy planning. Tumours usually remain localized, and are potentially curable with local radiation. The steep radiation dose-response relationships support the strategies of radiation dose escalation to increase local control. Two-dimensional simulator-based planning and CT planning have significant drawbacks in terms of accurate target volume definition. MRI has enhanced soft tissue delineation, but has to be fused with CT to allow dose calculation. Functional imaging using dynamic contrast enhanced CT or MRI sequences may allow improved knowledge of tumour function. Positron emission tomography (PET) may allow further physiological information to be determined. This review summarizes the current techniques in clinical development in this area.
Collapse
Affiliation(s)
- K Newbold
- The Royal Marsden NHS Trust, Fulham Road, London SW3 6JJ, UK
| | | | | | | | | | | | | | | |
Collapse
|
21
|
Ahnesjö A, Hårdemark B, Isacsson U, Montelius A. The IMRT information process—mastering the degrees of freedom in external beam therapy. Phys Med Biol 2006; 51:R381-402. [PMID: 16790914 DOI: 10.1088/0031-9155/51/13/r22] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
The techniques and procedures for intensity-modulated radiation therapy (IMRT) are reviewed in the context of the information process central to treatment planning and delivery of IMRT. A presentation is given of the evolution of the information based radiotherapy workflow and dose delivery techniques, as well as the volume and planning concepts for relating the dose information to image based patient representations. The formulation of the dose shaping process as an optimization problem is described. The different steps in the calculation flow for determination of machine parameters for dose delivery are described starting from the formulation of optimization objectives over dose calculation to optimization procedures. Finally, the main elements of the quality assurance procedure necessary for implementing IMRT clinically are reviewed.
Collapse
Affiliation(s)
- Anders Ahnesjö
- Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Akademiska Sjukhuset, SE-751 85 Uppsala, Sweden. anders.ahnesjo@
| | | | | | | |
Collapse
|
22
|
Ahmad S, Vlachaki MT. Impact of margin on tumour and normal tissue dosimetry in prostate cancer patients treated with IMRT using an endorectal balloon for prostate immobilization. ACTA ACUST UNITED AC 2005; 28:209-15. [PMID: 16506617 DOI: 10.1007/bf03178720] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
In IMRT treatment, margin for planning target volume is determined by organ motion and set-up error. The margin width that achieves the desired dose escalation, while minimizing normal tissue exposure is dependent upon patient immobilization and/or organ localization techniques. In this study, we compare the impact of margin width on the dosimetry of tumour and normal tissues using an endorectal balloon filled with 100 cc of air. Plans were generated for ten patients using margin widths of 0, 3, 5, 8 and 10 mm. The prescription dose to prostate and seminal vesicles was 70 Gy in 35 fractions with 15% of bladder allowed to receive above 65 Gy, 15% of rectum above 68 Gy and 10% of femurs above 45 Gy. Margins above 5 mm produced significantly lower mean doses for both prostate and seminal vesicles without affecting TCP. For normal tissues, mean doses, percent volumes above prescription constraints and NTCP increased as a function of margin width, especially when this was 5 mm or above. We conclude that planning with tighter margins of < or =5 mm improves IMRT dosimetry for prostate and normal tissues and is only possible when target localization and/or immobilization devices are routinely used.
Collapse
Affiliation(s)
- S Ahmad
- The University of Oklahoma Health Sciences Center, Department of Radiation Oncology, Oklahoma City 73104, USA.
| | | |
Collapse
|
23
|
Webb S. Intensity-modulated radiation therapy (IMRT): a clinical reality for cancer treatment, “any fool can understand this”. Br J Radiol 2005; 78 Spec No 2:S64-72. [PMID: 16306638 DOI: 10.1259/bjr/26711644] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Affiliation(s)
- S Webb
- Joint Department of Physics, Institute of Cancer Research (University of London) and Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey SM2 5PT, UK
| |
Collapse
|
24
|
Dragun AE, Harmon JF, Aguero EG. Defining targets and protecting normal tissues in inverse-planned IMRT for prostate, head and neck, and gynecologic cancers: a comparative review. ACTA ACUST UNITED AC 2005. [DOI: 10.1016/s1548-5315(11)70898-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
25
|
Hall EJ, Wuu CS. BJR Review of the Year 2004. Br J Radiol 2005; 78:672-3; author reply 673. [PMID: 15961855 DOI: 10.1259/bjr/12790920] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
26
|
|
27
|
Murthy V, Horwich A. Intensity Modulated Radiation Therapy. Eur J Cancer 2004; 40:2349-51. [PMID: 15519504 DOI: 10.1016/j.ejca.2004.06.029] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2004] [Accepted: 06/29/2004] [Indexed: 10/26/2022]
|
28
|
Abstract
Intensity-modulated radiotherapy (IMRT) has become established in many clinics round the world and is, arguably, technically feasible in any facility. Serial tomotherapy contributed an extensive role in its introduction into the mainstream in the second half of the 1990s. In tomotherapy, literally "slice therapy", highly conformal treatments are possible because of the advantages available within the treatment planning of the IMRT process. Currently the majority of clinics implementing IMRT are doing so using conventional clinical linear accelerators (Linacs) fitted with an integrated multileaf collimator (MLC). At this point in time we may wonder if there is any scope for further dramatic changes in this new technology. As we venture from IMRT initial implementation into image guided therapy it is clear that major changes in approach are still valid and needed. If, at each treatment fraction, we can ensure that treatments are delivered accurately by integration of volumetric imaging into on-line validation, then we can attempt higher levels of conformality. A new treatment machine, the helical tomotherapy system, is available that combines the benefits of tomotherapy with on-line volumetric imaging. In this article we will review this approach and explore its features.
Collapse
Affiliation(s)
- A W Beavis
- Department of Medical Physics, Hull and East Yorkshire NHS Trust and Post Graduate Medical Institute, University of Hull and Princess Royal Hospital, Saltshouse Road, Kingston Upon Hull HU8 9HE, UK
| |
Collapse
|